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Running title 
 
GABA receptor regulation of 5-HT firing 
 
Abstract 
 
Evidence from electrophysiological studies suggests that 5-HT neuronal firing in the 
dorsal raphe nucleus (DRN) may be regulated by both GABAA and GABAB receptors. 
Here we addressed the question of whether the activity of individual 5-HT neurons is 
regulated by both GABAA and GABAB receptors. In addition, we examined the 
concentration-response relationships of GABAA and GABAB receptor-activation and 
determined if GABA receptor regulation of 5-HT neuronal firing is altered by 
moderate alterations in circulating corticosterone. The activity of 5-HT neurons in the 
DRN of the rat was examined using in vitro extracellular electrophysiology.  The 
firing of all individual neurons tested was inhibited by both the GABAA receptor 
agonist 4,5,6,7-tetrahydroisoxazolo-[5,4-c]-pyridin-3-ol hydrochloride (THIP) (25 
μM) and the GABAB receptor agonist baclofen (1 μM). Responses to THIP (5, 10, 25 
μM) and baclofen (1, 3, 10 μM) were concentration dependent and attenuated by the 
GABAA and GABAB receptor antagonists, bicuculline (50 μM) and phaclofen (200 
μM), respectively. To examine the effects of corticosterone on the sensitivity of 5-HT 
neurons to GABA receptor activation, experiments were conducted on 
adrenalectomized animals with corticosterone maintained for two weeks at either a 
low or moderate level within the normal diurnal range. These changes in 
corticosterone levels had no significant effects on the 5-HT neuronal response to 
either GABAA or GABAB receptor-activation. The data indicate that the control of 
5-HT neuronal activity by GABA is mediated by both GABAA or GABAB receptors 
and that this control is insensitive to moderate changes in circulating glucocorticoid 
levels. 
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 Serotonergic neurons that innervate the forebrain have been implicated in a range of 
physiological systems and behaviours (Jacobs et al., 1990; Jacobs and Fornal, 1991). 
The dorsal raphe nucleus (DRN) contains the cell bodies of the majority of these 
serotonergic neurons (Steinbusch, 1981; Tork, 1985). The DRN also contains a large 
number of GABAergic interneurons (Nanopoulos et al., 1982; Belin et al., 1983; 
Stamp and Semba, 1995; Varga et al., 2001; 2003).  Recent evidence indicates that the 
DRN is also innervated  by GABAergic projection neurons (Sherin et al., 1998; 
Gervasoni et al., 2000).   
 
Electrophysiological studies have revealed that the firing activity of DRN 5-HT 
neurons is inhibited by application of the selective GABAB receptor agonist baclofen 
(Innis and Aghajanian, 1987), suggesting GABAB receptor modulation of 5-HT 
neuronal activity. On the otherhand, the inhibition of firing of DRN 5-HT neurons in 
response to GABA itself has been shown to be enhanced by benzodiazepines, 
suggesting mediation by GABAA receptors (Gallager, 1978). However, it is of interest 
that Smith and Gallager (1987) reported only partial blockade of the response to 
GABA by the GABAA receptor antagonist bicuculline and hence suggested that, in 
individual 5-HT neurons, the response to GABA may be partially mediated by both 
GABAA and GABAB receptor subtypes. However, no study has directly examined the 
effect of selective agonists of the two GABA receptor subtypes on individual DRN 
neurones. 
 
Data from binding studies also support the potential modulation of 5-HT neuronal 
activity by both GABAA and GABAB receptors, as both receptor subtypes have been 
shown to be expressed in the DRN (Bowery et al., 1987).  Furthermore, it has been 
reported that the majority of 5-HT neurons contain the α3 subunit of the GABAA 
receptor (Gao et al., 1993; Rodriguez-Pallares et al., 2001), and that GABAB receptors 
are expressed in almost all DRN 5-HT neurons (Wirtshafter and Sheppard, 2001; 
Varga et al., 2002).  Thus, although no triple labelling studies have been reported, 
taken together, these data suggest that individual 5-HT neurons in the DRN may 
express both GABAA and GABAB receptor subtypes. 
 
5-HT neurons of the DRN are reported to contain intracellular glucocorticoid 
receptors (Härfstrand et al., 1986) which may regulate transcription of 
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neurotransmitter receptors expressed on 5-HT neurons. Hence glucocorticoids may 
influence the response of 5-HT neurons to neurotransmitter inputs. Indeed, we have 
recently shown (Judge et al., 2003, 2004) that the sensitivity of 5-HT neurons to a1-
adrenoceptor-mediated excitation and 5-HT1A receptor-mediated inhibition is altered 
by moderate changes in glucocorticoid levels, similar to those reported in several 
psychiatric disorders (Weber et al., 2000; Yehuda, 2002). Studies in other brain areas 
have shown that GABAA receptors are also sensitive to (albeit gross) changes in the 
levels of the glucocorticoid hormone, corticosterone (Majewska et al., 1985; Orchinik 
et al., 1995; 2001), hence GABAergic regulation of 5-HT neuronal firing may also be 
sensitive to glucocorticoids. It has also been suggested that alterations in GABAB 
receptor function in the hippocampus of aged rats may be attributable to changes in 
corticosterone levels (Billard et al., 1995; Lamour et al., 1997), although direct 
evidence of this is lacking. Taken together these data support GABAA and/or GABAB 
receptor-mediated regulation of 5-HT neuronal firing may potentially be sensitive to 
moderate changes in the levels of circulating corticosterone.  
 
The aims of the present study were to firstly, determine whether individual 5-HT 
neurones in the DRN are regulated by both GABAA and GABAB receptors; secondly, 
establish concentration response levels for GABAA and GABAB receptors agonists; 
and thirdly, determine if this regulation is sensitive to moderate changes in circulating 
corticosterone levels. Selective GABAA and GABAB receptor agonists and 
antagonists were used to demonstrate GABA receptor involvement in the modulation 
of 5-HT neuronal firing using in vitro electrophysiology in a DRN slice preparation. 
To examine the effects of corticosterone on the sensitivity of 5-HT neurons to 
GABAA and GABAB receptor regulation, experiments were conducted in groups of 
animals that had had their circulating corticosterone levels maintained at one of two 
points within the normal diurnal range for two weeks.  
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Experimental procedures 
 
Animals 
All experiments were carried out in accordance with the UK Animals (Scientific 
procedures) act of 1986 and the European Community Council Directive of 24th 
November 1986 (86/609/EEC).  Male hooded Lister rats (Charles River, Kent) aged 
12-15 weeks (230-300g), were group housed under controlled conditions of 
temperature and humidity in a 12 h light/dark cycle (lights on 7 am).  All animals 
were allowed to acclimatise to the holding facilities for one week before interventions 
were made.  
 
Two series of studies were performed. The first involved characterization of GABA 
receptor-mediated inhibition using slices from naïve animals (n = 13). The second 
involved a comparison of GABA receptor-mediated inhibition in two groups of rats (n 
= 18) with corticosterone levels maintained at moderately different levels. In the 
second study no untreated (adrenally intact) or adrenalectomy only groups were 
included as the comparison was between groups with constant steroid levels. 
 
Corticosterone treatment 
Corticosterone was maintained at different levels for approximately two weeks by 
removing the adrenal glands and implanting slow release corticosterone/cholesterol 
pellets (100mg) made in-house (Meyer et al., 1979). Animals were anaesthetised with 
isoflurane,  the adrenal glands were removed by the dorsal approach and the muscles 
sutured.  Before the skin wound was sutured a subcutaneous pocket was made and 
animals were implanted with either a single 2 % corticosterone/98 % cholesterol 
pellet (low corticosterone group) or two 70 % corticosterone/30 % cholesterol pellets 
(moderate corticosterone group). All animals received peri-surgical analgesia with a 
non-steroidal anti-inflammatory drug (meloxicam or carprofen). After surgery, all 
animals were allowed ad libitum access to normal saline in addition to tap water. 
Animals were weighed daily and their general health assessed by visual inspection.  
 
At the time of surgery, rats destined for implantation with 2 % pellets weighed 191 ±  
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4 g (n = 9) and those receiving two 70 % pellets weighed 190 ± 3 g (n = 9).  Although 
rats with two 70 % pellets had lower weight gain than the 2 % group in the first few 
days after surgery, from day 4, both groups gained weight at a similar rate.  
 
Rats in their home cages were moved to a quiet room adjacent to the experimental 
room at least 12 h before sacrifice.  Animals were sacrificed by guillotine 13-16 days 
following surgery, between 8 and 9 am. The trunk blood was collected for the 
determination of serum corticosterone levels. Serum samples were stored frozen at 
-20˚C until assayed for corticosterone using a commercially available 
radioimmunoassay kit (Coat-a-Count, Diagnostic Products Corporation, Los Angeles, 
CA). The low corticosterone group had serum corticosterone of 25.5 ± 7.4 ng/ml 
(range: 0.1 - 61.6 ng/ml; n = 9) which was signficantly lower than that in the moderate 
corticosterone group (91.2 ± 7.9 ng/ml; range: 58.1 - 121.4 ng/ml; n = 9) (p < 0.0001 
unpaired t-test).  
 
Electrophysiology 
Animals were decapitated between 8 and 9 am. Some naïve animals were overdosed 
with isoflurane immediately before decapitation, while other naïve animals and all 
corticosterone-treated animals were decapitated without prior anaesthesia. In vitro 
electrophysiological recordings were made using methods previously described 
(Johnson et al., 2002). Briefly, the brain was submerged in ice cold oxygenated 
artificial cerebrospinal fluid (aCSF) (composition (mM): NaCl 124, MgSO4 2.4, 
KH2PO4 1.25, KCl 3.25, NaHCO3 26, CaCl2 2, D-glucose 10, pH 7.4) or sucrose slush 
(composition (mM): Sucrose: 200, HEPES 10, MgSO4 7, NaH2PO4 1.2, KCl 2.5, 
NaHCO3 25, CaCl2 0.5, D-glucose 10, pH 7.4). Coronal slices of the midbrain (400 
μm thick), containing the DRN, were cut using a vibrating microtome (Vibratome 
1000),  and then transferred to an interface perfusion chamber (1-3 slices per 
chamber) which was perfused with oxygenated aCSF (0.5 ml/min) at 36˚C.  
Throughout the experiment the aCSF contained the α1-adrenoceptor agonist 
phenylephrine (1 μM) in order to evoke 5-HT neuronal firing. 
 
Extracellular recordings were made from presumed 5-HT neurons in the DRN using 
glass microelectrodes (1.5 mm OD, Clarke Electromedical; 1-3 MΩ in vitro 
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impedance) filled with 2 M NaCl. Signals were amplified with a AC differential 
preamplifier (x1000). Spikes were discriminated by means of a pulse discriminator 
and the TTL pulses generated were fed to a PC via a computer interface (1401 or 
micro1401, CED, UK) at a sampling rate of 100 Hz. Data were collected using Spike2 
software (version 4, CED, UK). At the start of the experiment the waveform of the 
signal was also recorded at a sampling rate of 10 kHz so the individual spike 
characteristics could be examined.  Neurons were identified as putative 5-HT neurons 
on the basis of their location (in the DRN), basal electrophysiological characteristics 
(regular single spikes 1-2 ms wide with a slow frequency of 0.2-4 Hz (VanderMaelen 
and Aghajanian, 1983; Allers and Sharp, 2003)), and their inhibitory response to 5-HT 
(25-100 mM). Following a period of recording of basal firing activity, drugs were 
applied via the perfusion medium at least 4 minutes apart. Agonists were applied for 
two minutes, antagonists were applied for three minutes before the agonist application 
as well as during the two minute agonist application. 
 
Materials 
NaCl, MgSO4, KH2PO4, KCl, NaHCO3 and sucrose were purchased from BDH 
Laboratory Supplies (UK). CaCl2, D-(+)-glucose, HEPES, corticosterone, cholesterol, 
L-phenylephrine hydrochloride, 5-HT hydrochloride and (-) -bicuculline methiodide 
were purchased from Sigma (UK). 4,5,6,7-tetrahydroisoxazolo-[5,4-c]-pyridin-3-ol 
hydrochloride (THIP), (RS) baclofen and (RS) phaclofen were purchased from Tocris 
(UK). 
 
Data analysis and statistics 
Electrophysiological data were analysed offline from the firing rate data collected on 
Spike 2 (CED, UK).  Basal firing was determined in a 120 s period at the start of the 
recording and is expressed in Hz.  Responses to THIP and baclofen were determined 
as the firing rate in a 120s period covering the maximum change in baseline. This 
response was expressed as a percentage change (decrease) relative to the firing rate in 
the 120s immediately before the application of the drug.  For corticosterone-treated 
animals, the rat was considered to be the experimental unit. The responses of the 
individual neurons from an animal were averaged and a group mean calculated from 
these average responses. Data presented are individual examples or the mean ± SEM. 
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Within group differences were analysed by paired t-test and between group 
differences were analysed by unpaired t-test or two-way repeated measures ANOVA. 
Correlations were assessed using Pearson product moment. 
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Results 
 
Modulation of 5-HT activity by GABAA and GABAB receptors in naïve animals 
In the presence of phenylephrine (1μM), 5-HT neurons in the DRN of slices taken 
from naïve animals fired slowly (mean basal firing rate: 1.2 ± 0.1 Hz; n = 42) and in a 
regular pattern. 5-HT (25 μM), inhibited basal firing in all neurons (mean inhibition: 
78 ± 4 %; range: 22 – 100 %; n = 42). The percentage coefficient of variation of the 
interspike interval calculated for 17 of these presumed 5-HT neurons was found to 
range from 7 – 47 % (mean: 21 %), indicating that the neurons fired in a regular 
pattern. These 17 neurons were tested with both the GABAA receptor agonist THIP 
(25 μM) and the GABAB receptor agonist baclofen (1 μM). The firing in each of these 
neurons decreased in response to both THIP (mean inhibition 65 ± 8 %) and baclofen 
(mean inhibition 57 ± 8 %). However, the magnitude of effect was variable (Fig. 1) 
with the response to THIP ranging from 5 – 100 % inhibition and the response to 
baclofen ranging from 16 – 100%. There was no correlation between responses to 
THIP and baclofen in individual neurons. 
 
5-HT neurons (n = 11) which were tested with increasing concentrations of THIP (5, 
10, 25 μM) displayed a concentration-dependent inhibitory response (Fig. 2A,B). The 
inhibitory action of THIP (25 μM) was almost completely blocked in the presence of 
the GABAA receptor antagonist bicuculline (50 μM) (p < 0.0001 paired t-test; n = 6) 
(Fig. 2C). In the presence of bicuculline (50 μM) basal firing was not altered (Fig. 
2A). 
 
Fourteen 5-HT neurons which were tested with increasing concentrations of baclofen 
(1, 3, 10 μM) also displayed a concentration-dependent inhibitory response (Fig. 
3A,B). The inhibitory response to baclofen (3 μM) was partially attenuated in the 
presence of the GABAB receptor antagonist phaclofen (200 μM) (p < 0.0005 paired t-
test; n = 7) (Fig. 3C). Basal firing was not altered by phaclofen (200 μM) alone (Fig. 
3A). 
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Effect of in vivo corticosterone treatment on GABAA and GABAB receptor modulation 
of 5-HT activity   
The basal firing of 5-HT neurons in the continuous presence of phenylephrine (1μM) 
was not significantly different between animals in the low corticosterone group (1.52 
± 0.21 Hz; n = 9) and the moderate corticosterone group (1.48 ± 0.12 Hz; n = 9). The 
inhibitory response to 5-HT (50 μm) was lower in animals in the low corticosterone 
group (68 ± 4 %; n = 9) than in the moderate corticosterone group (78 ± 5 %; n = 9) 
but this difference was not statistically significant (p > 0.05 unpaired t-test). 
Application of THIP (5,10, 25 μM) inhibited firing in neurons from both groups of 
animals (Fig. 4A). Two-way ANOVA revealed a highly significant main effect of 
THIP concentration (F2,32 = 177; p < 0.001) but no significant difference between the 
two corticosterone-treated groups. The firing of 5-HT neurons in both groups of 
animals also decreased following the application of baclofen (0.3,1,3 μM) (Fig. 4B). 
The inhibition of 5-HT neuronal firing by baclofen was concentration-dependent (F2,32 
= 163; p < 0.001), but there was no significant difference in the response to baclofen 
between animals in the low corticosterone group and animals in the moderate 
corticosterone group. 
 
Discussion 
 
The present study aimed to clarify the characteristics of the GABA receptor-mediated  
regulation of 5-HT neuronal firing in the DRN and to examine the impact of moderate 
changes in corticosterone levels on the sensitivity of the neurons to  GABA receptor-
activation.  The firing of 5-HT neurons was inhibited by THIP and baclofen. 
Responses to THIP and baclofen were concentration dependent and were attenuated 
by the GABAA receptor antagonist bicuculline and the GABAB receptor antagonist 
phaclofen, respectively. Importantly, all individual neurons tested (in both naïve and 
corticosterone-treated animals) were found to respond to both GABAA and GABAB 
receptor agonists. Finally, we found that clamping corticosterone levels at low and 
moderate ranges failed to alter the response of presumed 5-HT neurons to either 
GABAA and GABAB receptor-mediated inhibition. 
 
 11 
Characterization of GABA receptor-mediated regulation of 5-HT neuronal firing  
The selective GABAA receptor agonist THIP (Frolund et al., 1995) caused a clear 
concentration dependent inhibition of firing of 5-HT neurons. The inhibitory actions 
of THIP were completely blocked by bicuculline consistent with the action of THIP 
being GABAA receptor mediated (Bowery et al., 1984).  GABAA receptors on 5-HT 
neurons in the DRN reportedly contain the a3 subunit (Gao et al., 1993; Rodriguez-
Pallares et al., 2001). THIP is reported to have a lower affinity for GABAA receptors 
containing the a3 subunit than other α subunits and moreover is reported to be a 
partial agonist in oocytes expressing recombinant GABAA receptors containing the a3 
subunit (Ebert et al., 1997). However, in the present study THIP was found to be 
potent and efficacious in inhibiting 5-HT neuronal activity.   
 
Baclofen also caused inhibition of firing and again the effect was concentration 
dependent.  The effect of baclofen was attenuated by phaclofen indicative of its 
mediation by GABAB receptors (Kerr et al., 1987).  The effect of phaclofen, though 
marked, did not approach complete blockade of the action of baclofen. However, only 
one concentration was tested and it is possible that a higher concentration of 
phaclofen would have had a more complete effect.  Interestingly, neither bicuculline 
nor phaclofen alone increased firing. Although it has been previously shown that 
some 5-HT neurones display spontaneous GABAergic inhibitory postsynaptic 
currents in the slice preparation (Liu et al., 2000), under the recording conditions used 
in the present study we found no evidence of tonic GABAergic regulation of firing 
rate. 
 
It has previously been reported that the application of the GABAB agonist, baclofen 
(Innis and Aghajanian, 1987; Smith and Gallager, 1987) inhibits the firing of 5-HT 
neurons in the DRN, as does the application of the selective the GABAA agonist, 
muscimol (Sakai and Crochet, 2001).  Hence, the present data showing GABAA and 
GABAB receptor mediated inhibition of 5-HT neuronal firing are consistent with these 
previous data.  Importantly, in the present study we found that all DRN 5-HT neurons 
tested with both THIP and baclofen showed inhibitory responses to both agonists.  
This was the case both in naïve animals and in those from the different corticosterone 
treatment groups.  Thus, the bicuculline-insensitive inhibition of 5-HT neuronal firing 
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induced by GABA noted by Smith and Gallager (1987) may be explained by the fact 
that the activity of individual neurons is subject to modulation by both GABAA and 
GABAB receptor subtypes.  Futhermore, these functional data are consistent with 
immunocytochemical studies in which it has been found that the vast majority of 
5-HT neurons in DRN express the α3 subunit of the GABAA receptor (Gao et al., 
1993; Rodriguez-Pallares et al., 2001) and also that almost all 5-HT neurons express 
GABAB receptors (Wirtshafter and Sheppard, 2001; Varga et al., 2002).  
 
Although both GABAA and GABAB receptors inhibit 5-HT neuronal firing it is likely 
that they do so via different molecular mechanisms. Thus, GABAA receptor activation 
opens a chloride channel (Tallman and Gallager, 1985), whilst the GABAB receptor is 
reported to hyperpolarize neurons via activation of a G-protein linked inward 
rectifying potassium channel (GIRK; Innis and Aghajanian, 1987; Williams et al., 
1988). It is unclear whether the two receptor subtypes have different subcellular 
localizations or are differentially distributed in synaptic and extrasynaptic domains, 
but such factors may influence their functional roles (see below).   
 
In vivo studies have demonstrated that intra-raphe application of both GABAA and 
GABAB receptor agonists inhibits 5-HT release in the forebrain (Abellán et al., 2000; 
Tao and Auerbach, 2000). The present data would be consistent with these effects on 
release being a consequence of inhibition of 5-HT firing. Although, our data suggest a 
lack of GABAergic tone in the slice preparation, it is of interest that in vivo 
electrophysiological and microdialysis studies are indicative of significant GABAA 
receptor-mediated tone regulating 5-HT neuronal firing and release at least at some 
phases of the sleep-wake cycle (Levine and Jacobs, 1992; Gervasoni et al., 2000). In 
contrast, evidence suggests that GABAB receptor-activation does not normally 
contribute to the inhibitory regulation of 5-HT neuronal activity (Tao et al., 1996). 
Thus, whilst the GABAA receptor may be regarded as a tonic regulator, the GABAB 
receptor may be involved in phasic regulation.   
 
Effects of corticosterone on GABA receptor sensitivity  
The above data indicate that GABA receptors play a vital role in the regulation of 
5-HT neuronal activity.  Hence, changes in their sensitivity may have important 
consequences for 5-HT neuronal activity within the brain. This study also sought to 
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determine if the sensitivity of  DRN 5-HT neurons to GABAA and GABAB receptor-
activation is altered by moderate changes in circulating corticosterone levels within 
the physiological range. THIP and baclofen responses were compared in two groups 
of animals with serum corticosterone clamped at different levels within the normal 
diurnal range. Animals in the low corticosterone group had serum corticosterone 
levels close to the trough of the normal diurnal rhythm, whilst the moderate 
corticosterone group had levels in the mid to high diurnal range (Judge et al., 2003, 
2004).  As there is evidence that the effects of corticosterone on the levels of mRNA 
of GABAA receptor subunits elsewhere in the brain is delayed (Kang et al., 1991; 
Stone et al., 2001), experiments were conducted after two weeks of corticosterone 
treatment.  
  
We found that moderate changes in circulating corticosterone levels within the 
physiological range had no significant effect on the sensitivity of DRN 5-HT neurons 
to GABAA receptor-activation. Thus across the whole concentration range tested, 
responses were similar in the low and moderate corticosterone groups. This is perhaps 
surprising since several studies have shown that the expression and pharmacological 
properties of GABAA receptors in other brain regions is sensitive to corticosterone 
(Majewska et al., 1985; Wilson and Biscardi, 1994; Orchinik et al., 1995, 2001). 
Although it is not immediately clear why in the present study we found no effect of 
alterations in corticosterone level, three possibilities present themselves: First, the 
differences in corticosterone levels in our two experimental groups may not have been 
sufficient to induce changes.  However, Orchinik et al. (1994) observed that variations 
in corticosterone of similar magnitude to those used here caused changes in 
hippocampal expression of mRNAs coding for GABAA subunits.  Moreover, we have 
previously shown that moderate changes in corticosterone levels alter the sensitivity 
of 5-HT neurones to a1-adrenoceptor-mediated excitation and 5-HT1A receptor-
mediated inhibition (Judge et al., 2003, 2004). Second, changes may be mediated 
through the mineralocorticoid rather than glucocorticoid receptor. Indeed, the ratio of 
mineralocorticoid to glucocorticoid receptors is far higher in hippocampus, where 
changes have been observed (Majewska et al., 1985; Wilson and Biscardi, 1994; 
Orchinik et al., 1995, 2001), than in the DRN (R. McQuade pers. comm.).   However, 
changes have also been observed in the cortex and hypothalamus (Majewska et al., 
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1985; Wilson and Biscardi, 1994; Orchinik et al., 1995) which, like the DRN, contain 
a low ratio of mineralocorticoid to glucocorticoid receptors (R. McQuade pers. 
comm.).  Third, those subunits which make up the GABAA receptor in the DRN may 
not be sensitive to corticosterone.  This last explanation seems the most plausible as 
the influence of corticosterone on the GABAA receptor has been reported to be 
subunit-specific (Orchinik et al., 1995).  To our knowledge the a3 subunit, which is 
expressed by DRN 5-HT neurons has not been shown to be corticosterone sensitive.   
 
We also found no effect of alterations in corticosterone on the response of 5-HT 
neurons to baclofen. The potential influence of corticosterone on the function of the 
GABAB receptor has been little studied.  In one study chronic corticosterone was 
shown to decrease the GABAB receptor modulation of cyclic AMP production in the 
cortex (Duman et al., 1986). However, in the DRN the GABAB receptor is coupled to 
a GIRK (Innis and Aghajanian, 1987; Williams et al., 1988) rather than to adenylate 
cyclase.  It has previously been shown that the expression of the mRNA encoding one 
of the GIRK subunits to which GABAB receptors in the DRN are coupled is 
influenced by corticosterone (Fairchild et al., 2003).  However, the present data would 
suggest that this is not mirrored in a functional change.  
 
Identity of neurons recorded 
In the light of a recent paper showing that some neurons in the DRN, which fire 
slowly and regularly, are not serotonergic (Allers and Sharp, 2003), it is important to 
comment on the identity and characteristics of the neurons recorded here.  It has 
previously been reported that GABAB receptors in the DRN are limited almost 
exclusively to 5-HT neurons (Wirtshafter and Sheppard, 2001).  Although we initially 
identified neurons on the basis of electrophysiological characteristics and inhibition 
by 5-HT, our finding that all neurons tested were inhibited by baclofen would indicate 
that it is highly unlikely that any of the neurons recorded here were non-serotonergic. 
It is possible that those slow firing, non-serotonergic, DRN neurons recorded in vivo 
(Allers and Sharp, 2003) are silent in vitro and therefore are not routinely recorded 
with the extracellular slice methodology employed here. 
 
Summary 
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In summary the present data demonstrate that the firing of 5-HT neurons in the DRN 
is regulated by GABAA and GABAB receptors and that individual neurons are 
influenced by both receptor subtypes. The sensitivity of 5-HT neurons to this GABA 
receptor-mediated regulation is not sensitive to moderate changes in corticosterone 
level. 
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Figure 1. Inhibitory responses of individual DRN 5-HT neurones to THIP (25 mM) 
and baclofen (Bac; 1 mM).  A) Recording from an individual neurone showing the 
decrease in basal firing rate following the application of THIP and baclofen for 
periods of 2 min as indicated by the bars.  Note that recordings have not been 
corrected for the perfusion lag (approximately 2 min). B) Recording from another 
individual neurone showing that the relative magnitude of the inhibitory responses to 
THIP and baclofen between neurones are variable. 
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Figure 2. Inhibitory responses of DRN 5-HT neurones to the GABAA receptor 
agonist THIP, in the absence and presence of the GABAA receptor antagonist, 
bicuculline (Bic). (A) Example of a recording showing the inhibitory responses to 
increasing concentrations of THIP of an individual 5-HT neurone in the absence and 
presence of bicuculline. Recording was made in the presence of 1 mM phenylephrine 
throughout.  THIP (5, 10 and 25 mM) was applied for periods of 2 min as indicated by 
the bars.  Note that recordings have not been corrected for the perfusion lag 
(approximately 2 min). THIP caused a concentration-dependent inhibition which 
reversed readily on wash-out of the drug.  Bicuculline (50 mM) applied for 3 min did 
not cause a change in basal firing but blocked the inhibitory response to THIP 
(25 mM). (B) Concentration-response relationships for inhibitory responses to THIP 
displayed by 5-HT neurones (n = 11). Data shown are mean ± SEM. (C) Inhibitory 
responses to THIP (25 mM) in the absence and presence of bicuculline (50 mM) 
displayed in individual 5-HT neurones. The responses from the same neurone are 
joined by a line.  
 24 
0
25
50
75
100
1 3 10
[Baclofen] (mM)
In
h
ib
it
io
n
 o
f 
fi
r
in
g
 (
%
)
0
25
50
75
100
Baclofen Baclofen and
Phaclofen
In
h
ib
it
io
n
 o
f 
fi
ri
n
g
 (
%
)
5 minutes
0
5
10
15
1 mM Bac 3 mM Bac 10 mM Bac
200 mM Phac
3 mM Bac
S
p
ik
es
/1
0
 s
 b
in
A
B C
 
Figure 3. Inhibitory responses of DRN 5-HT neurones to the GABAB receptor agonist 
baclofen, in the absence and presence of the GABAB receptor antagonist, phaclofen. 
(A) Example of a recording showing the inhibitory responses to increasing 
concentrations of baclofen of an individual 5-HT neurone in the absence and presence 
of phaclofen. The recording was made in the continuous presence of 1 
mM  phenylephrine and increasing concentrations of baclofen (1, 3 and 10 mM Bac) 
were applied for 2 min as indicated by the bars.  Note that the recording has not been 
corrected for the lag-time of the perfusion system (approximately 2 min).  Baclofen 
caused a concentration-dependent inhibition which readily reversed on wash-out.  
Application of phaclofen (200 mM Phac) for 3 min did not cause a change in basal 
firing but partially antagonized the inhibitory response to baclofen (3 mM). (B) 
Concentration-dependent inhibitory responses of 5-HT neurones to baclofen (n = 14). 
Data shown are mean ± SEM.  (C) The inhibitory responses of individual 5-HT 
neurones to baclofen (3 mM) in the absence and presence of phaclofen (200 mM). The 
responses from the same neurone are joined by a line.  
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Figure 4. Concentration-response relationships responses to GABA receptor agonists 
displayed by 5-HT neurones in slices from rats in the low corticosterone group (closed 
symbols; n = 9) and moderate corticosterone group (open symbols; n = 9).  (A) 
Inhibitory responses to increasing concentrations of THIP. (B) Inhibitory responses to 
baclofen. Data shown are mean ± SEM. 
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Running title 
 
GABA receptor regulation of 5-HT firing 
 
Abstract 
 
Evidence from electrophysiological studies suggests that 5-HT neuronal firing in the 
dorsal raphe nucleus (DRN) may be regulated by both GABAA and GABAB receptors. 
Here we addressed the question of whether the activity of individual 5-HT neurons is 
regulated by both GABAA and GABAB receptors. In addition, we examined the 
concentration-response relationships of GABAA and GABAB receptor-activation and 
determined if GABA receptor regulation of 5-HT neuronal firing is altered by 
moderate alterations in circulating corticosterone. The activity of 5-HT neurons in the 
DRN of the rat was examined using in vitro extracellular electrophysiology.  The 
firing of all individual neurons tested was inhibited by both the GABAA receptor 
agonist 4,5,6,7-tetrahydroisoxazolo-[5,4-c]-pyridin-3-ol hydrochloride (THIP) (25 
μM) and the GABAB receptor agonist baclofen (1 μM). Responses to THIP (5, 10, 25 
μM) and baclofen (1, 3, 10 μM) were concentration dependent and attenuated by the 
GABAA and GABAB receptor antagonists, bicuculline (50 μM) and phaclofen (200 
μM), respectively. To examine the effects of corticosterone on the sensitivity of 5-HT 
neurons to GABA receptor activation, experiments were conducted on 
adrenalectomized animals with corticosterone maintained for two weeks at either a 
low or moderate level within the normal diurnal range. These changes in 
corticosterone levels had no significant effects on the 5-HT neuronal response to 
either GABAA or GABAB receptor-activation. The data indicate that the control of 
5-HT neuronal activity by GABA is mediated by both GABAA or GABAB receptors 
and that this control is insensitive to moderate changes in circulating glucocorticoid 
levels. 
 
Author Keywords 
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 Serotonergic neurons that innervate the forebrain have been implicated in a range of 
physiological systems and behaviours (Jacobs et al., 1990; Jacobs and Fornal, 1991). 
The dorsal raphe nucleus (DRN) contains the cell bodies of the majority of these 
serotonergic neurons (Steinbusch, 1981; Tork, 1985). The DRN also contains a large 
number of GABAergic interneurons (Nanopoulos et al., 1982; Belin et al., 1983; 
Stamp and Semba, 1995; Varga et al., 2001; 2003).  Recent evidence indicates that the 
DRN is also innervated  by GABAergic projection neurons (Sherin et al., 1998; 
Gervasoni et al., 2000).   
 
Electrophysiological studies have revealed that the firing activity of DRN 5-HT 
neurons is inhibited by application of the selective GABAB receptor agonist baclofen 
(Innis and Aghajanian, 1987), suggesting GABAB receptor modulation of 5-HT 
neuronal activity. On the otherhand, the inhibition of firing of DRN 5-HT neurons in 
response to GABA itself has been shown to be enhanced by benzodiazepines, 
suggesting mediation by GABAA receptors (Gallager, 1978). However, it is of interest 
that Smith and Gallager (1987) reported only partial blockade of the response to 
GABA by the GABAA receptor antagonist bicuculline and hence suggested that, in 
individual 5-HT neurons, the response to GABA may be partially mediated by both 
GABAA and GABAB receptor subtypes. However, no study has directly examined the 
effect of selective agonists of the two GABA receptor subtypes on individual DRN 
neurones. 
 
Data from binding studies also support the potential modulation of 5-HT neuronal 
activity by both GABAA and GABAB receptors, as both receptor subtypes have been 
shown to be expressed in the DRN (Bowery et al., 1987).  Furthermore, it has been 
reported that the majority of 5-HT neurons contain the α3 subunit of the GABAA 
receptor (Gao et al., 1993; Rodriguez-Pallares et al., 2001), and that GABAB receptors 
are expressed in almost all DRN 5-HT neurons (Wirtshafter and Sheppard, 2001; 
Varga et al., 2002).  Thus, although no triple labelling studies have been reported, 
taken together, these data suggest that individual 5-HT neurons in the DRN may 
express both GABAA and GABAB receptor subtypes. 
 
5-HT neurons of the DRN are reported to contain intracellular glucocorticoid 
receptors (Härfstrand et al., 1986) which may regulate transcription of 
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neurotransmitter receptors expressed on 5-HT neurons. Hence glucocorticoids may 
influence the response of 5-HT neurons to neurotransmitter inputs. Indeed, we have 
recently shown (Judge et al., 2003, 2004) that the sensitivity of 5-HT neurons to a1-
adrenoceptor-mediated excitation and 5-HT1A receptor-mediated inhibition is altered 
by moderate changes in glucocorticoid levels, similar to those reported in several 
psychiatric disorders (Weber et al., 2000; Yehuda, 2002). Studies in other brain areas 
have shown that GABAA receptors are also sensitive to (albeit gross) changes in the 
levels of the glucocorticoid hormone, corticosterone (Majewska et al., 1985; Orchinik 
et al., 1995; 2001), hence GABAergic regulation of 5-HT neuronal firing may also be 
sensitive to glucocorticoids. It has also been suggested that alterations in GABAB 
receptor function in the hippocampus of aged rats may be attributable to changes in 
corticosterone levels (Billard et al., 1995; Lamour et al., 1997), although direct 
evidence of this is lacking. Taken together these data support GABAA and/or GABAB 
receptor-mediated regulation of 5-HT neuronal firing may potentially be sensitive to 
moderate changes in the levels of circulating corticosterone.  
 
The aims of the present study were to firstly, determine whether individual 5-HT 
neurones in the DRN are regulated by both GABAA and GABAB receptors; secondly, 
establish concentration response levels for GABAA and GABAB receptors agonists; 
and thirdly, determine if this regulation is sensitive to moderate changes in circulating 
corticosterone levels. Selective GABAA and GABAB receptor agonists and 
antagonists were used to demonstrate GABA receptor involvement in the modulation 
of 5-HT neuronal firing using in vitro electrophysiology in a DRN slice preparation. 
To examine the effects of corticosterone on the sensitivity of 5-HT neurons to 
GABAA and GABAB receptor regulation, experiments were conducted in groups of 
animals that had had their circulating corticosterone levels maintained at one of two 
points within the normal diurnal range for two weeks.  
 
 5 
Experimental procedures 
 
Animals 
All experiments were carried out in accordance with the UK Animals (Scientific 
procedures) act of 1986 and the European Community Council Directive of 24th 
November 1986 (86/609/EEC).  Male hooded Lister rats (Charles River, Kent) aged 
12-15 weeks (230-300g), were group housed under controlled conditions of 
temperature and humidity in a 12 h light/dark cycle (lights on 7 am).  All animals 
were allowed to acclimatise to the holding facilities for one week before interventions 
were made.  
 
Two series of studies were performed. The first involved characterization of GABA 
receptor-mediated inhibition using slices from naïve animals (n = 13). The second 
involved a comparison of GABA receptor-mediated inhibition in two groups of rats (n 
= 18) with corticosterone levels maintained at moderately different levels. In the 
second study no untreated (adrenally intact) or adrenalectomy only groups were 
included as the comparison was between groups with constant steroid levels. 
 
Corticosterone treatment 
Corticosterone was maintained at different levels for approximately two weeks by 
removing the adrenal glands and implanting slow release corticosterone/cholesterol 
pellets (100mg) made in-house (Meyer et al., 1979). Animals were anaesthetised with 
isoflurane,  the adrenal glands were removed by the dorsal approach and the muscles 
sutured.  Before the skin wound was sutured a subcutaneous pocket was made and 
animals were implanted with either a single 2 % corticosterone/98 % cholesterol 
pellet (low corticosterone group) or two 70 % corticosterone/30 % cholesterol pellets 
(moderate corticosterone group). All animals received peri-surgical analgesia with a 
non-steroidal anti-inflammatory drug (meloxicam or carprofen). After surgery, all 
animals were allowed ad libitum access to normal saline in addition to tap water. 
Animals were weighed daily and their general health assessed by visual inspection.  
 
At the time of surgery, rats destined for implantation with 2 % pellets weighed 191 ±  
 6 
4 g (n = 9) and those receiving two 70 % pellets weighed 190 ± 3 g (n = 9).  Although 
rats with two 70 % pellets had lower weight gain than the 2 % group in the first few 
days after surgery, from day 4, both groups gained weight at a similar rate.  
 
Rats in their home cages were moved to a quiet room adjacent to the experimental 
room at least 12 h before sacrifice.  Animals were sacrificed by guillotine 13-16 days 
following surgery, between 8 and 9 am. The trunk blood was collected for the 
determination of serum corticosterone levels. Serum samples were stored frozen at 
-20˚C until assayed for corticosterone using a commercially available 
radioimmunoassay kit (Coat-a-Count, Diagnostic Products Corporation, Los Angeles, 
CA). The low corticosterone group had serum corticosterone of 25.5 ± 7.4 ng/ml 
(range: 0.1 - 61.6 ng/ml; n = 9) which was signficantly lower than that in the moderate 
corticosterone group (91.2 ± 7.9 ng/ml; range: 58.1 - 121.4 ng/ml; n = 9) (p < 0.0001 
unpaired t-test).  
 
Electrophysiology 
Animals were decapitated between 8 and 9 am. Some naïve animals were overdosed 
with isoflurane immediately before decapitation, while other naïve animals and all 
corticosterone-treated animals were decapitated without prior anaesthesia. In vitro 
electrophysiological recordings were made using methods previously described 
(Johnson et al., 2002). Briefly, the brain was submerged in ice cold oxygenated 
artificial cerebrospinal fluid (aCSF) (composition (mM): NaCl 124, MgSO4 2.4, 
KH2PO4 1.25, KCl 3.25, NaHCO3 26, CaCl2 2, D-glucose 10, pH 7.4) or sucrose slush 
(composition (mM): Sucrose: 200, HEPES 10, MgSO4 7, NaH2PO4 1.2, KCl 2.5, 
NaHCO3 25, CaCl2 0.5, D-glucose 10, pH 7.4). Coronal slices of the midbrain (400 
μm thick), containing the DRN, were cut using a vibrating microtome (Vibratome 
1000),  and then transferred to an interface perfusion chamber (1-3 slices per 
chamber) which was perfused with oxygenated aCSF (0.5 ml/min) at 36˚C.  
Throughout the experiment the aCSF contained the α1-adrenoceptor agonist 
phenylephrine (1 μM) in order to evoke 5-HT neuronal firing. 
 
Extracellular recordings were made from presumed 5-HT neurons in the DRN using 
glass microelectrodes (1.5 mm OD, Clarke Electromedical; 1-3 MΩ in vitro 
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impedance) filled with 2 M NaCl. Signals were amplified with a AC differential 
preamplifier (x1000). Spikes were discriminated by means of a pulse discriminator 
and the TTL pulses generated were fed to a PC via a computer interface (1401 or 
micro1401, CED, UK) at a sampling rate of 100 Hz. Data were collected using Spike2 
software (version 4, CED, UK). At the start of the experiment the waveform of the 
signal was also recorded at a sampling rate of 10 kHz so the individual spike 
characteristics could be examined.  Neurons were identified as putative 5-HT neurons 
on the basis of their location (in the DRN), basal electrophysiological characteristics 
(regular single spikes 1-2 ms wide with a slow frequency of 0.2-4 Hz (VanderMaelen 
and Aghajanian, 1983; Allers and Sharp, 2003)), and their inhibitory response to 5-HT 
(25-100 mM). Following a period of recording of basal firing activity, drugs were 
applied via the perfusion medium at least 4 minutes apart. Agonists were applied for 
two minutes, antagonists were applied for three minutes before the agonist application 
as well as during the two minute agonist application. 
 
Materials 
NaCl, MgSO4, KH2PO4, KCl, NaHCO3 and sucrose were purchased from BDH 
Laboratory Supplies (UK). CaCl2, D-(+)-glucose, HEPES, corticosterone, cholesterol, 
L-phenylephrine hydrochloride, 5-HT hydrochloride and (-) -bicuculline methiodide 
were purchased from Sigma (UK). 4,5,6,7-tetrahydroisoxazolo-[5,4-c]-pyridin-3-ol 
hydrochloride (THIP), (RS) baclofen and (RS) phaclofen were purchased from Tocris 
(UK). 
 
Data analysis and statistics 
Electrophysiological data were analysed offline from the firing rate data collected on 
Spike 2 (CED, UK).  Basal firing was determined in a 120 s period at the start of the 
recording and is expressed in Hz.  Responses to THIP and baclofen were determined 
as the firing rate in a 120s period covering the maximum change in baseline. This 
response was expressed as a percentage change (decrease) relative to the firing rate in 
the 120s immediately before the application of the drug.  For corticosterone-treated 
animals, the rat was considered to be the experimental unit. The responses of the 
individual neurons from an animal were averaged and a group mean calculated from 
these average responses. Data presented are individual examples or the mean ± SEM. 
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Within group differences were analysed by paired t-test and between group 
differences were analysed by unpaired t-test or two-way repeated measures ANOVA. 
Correlations were assessed using Pearson product moment. 
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Results 
 
Modulation of 5-HT activity by GABAA and GABAB receptors in naïve animals 
In the presence of phenylephrine (1μM), 5-HT neurons in the DRN of slices taken 
from naïve animals fired slowly (mean basal firing rate: 1.2 ± 0.1 Hz; n = 42) and in a 
regular pattern. 5-HT (25 μM), inhibited basal firing in all neurons (mean inhibition: 
78 ± 4 %; range: 22 – 100 %; n = 42). The percentage coefficient of variation of the 
interspike interval calculated for 17 of these presumed 5-HT neurons was found to 
range from 7 – 47 % (mean: 21 %), indicating that the neurons fired in a regular 
pattern. These 17 neurons were tested with both the GABAA receptor agonist THIP 
(25 μM) and the GABAB receptor agonist baclofen (1 μM). The firing in each of these 
neurons decreased in response to both THIP (mean inhibition 65 ± 8 %) and baclofen 
(mean inhibition 57 ± 8 %). However, the magnitude of effect was variable (Fig. 1) 
with the response to THIP ranging from 5 – 100 % inhibition and the response to 
baclofen ranging from 16 – 100%. There was no correlation between responses to 
THIP and baclofen in individual neurons. 
 
5-HT neurons (n = 11) which were tested with increasing concentrations of THIP (5, 
10, 25 μM) displayed a concentration-dependent inhibitory response (Fig. 2A,B). The 
inhibitory action of THIP (25 μM) was almost completely blocked in the presence of 
the GABAA receptor antagonist bicuculline (50 μM) (p < 0.0001 paired t-test; n = 6) 
(Fig. 2C). In the presence of bicuculline (50 μM) basal firing was not altered (Fig. 
2A). 
 
Fourteen 5-HT neurons which were tested with increasing concentrations of baclofen 
(1, 3, 10 μM) also displayed a concentration-dependent inhibitory response (Fig. 
3A,B). The inhibitory response to baclofen (3 μM) was partially attenuated in the 
presence of the GABAB receptor antagonist phaclofen (200 μM) (p < 0.0005 paired t-
test; n = 7) (Fig. 3C). Basal firing was not altered by phaclofen (200 μM) alone (Fig. 
3A). 
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Effect of in vivo corticosterone treatment on GABAA and GABAB receptor modulation 
of 5-HT activity   
The basal firing of 5-HT neurons in the continuous presence of phenylephrine (1μM) 
was not significantly different between animals in the low corticosterone group (1.52 
± 0.21 Hz; n = 9) and the moderate corticosterone group (1.48 ± 0.12 Hz; n = 9). The 
inhibitory response to 5-HT (50 μm) was lower in animals in the low corticosterone 
group (68 ± 4 %; n = 9) than in the moderate corticosterone group (78 ± 5 %; n = 9) 
but this difference was not statistically significant (p > 0.05 unpaired t-test). 
Application of THIP (5,10, 25 μM) inhibited firing in neurons from both groups of 
animals (Fig. 4A). Two-way ANOVA revealed a highly significant main effect of 
THIP concentration (F2,32 = 177; p < 0.001) but no significant difference between the 
two corticosterone-treated groups. The firing of 5-HT neurons in both groups of 
animals also decreased following the application of baclofen (0.3,1,3 μM) (Fig. 4B). 
The inhibition of 5-HT neuronal firing by baclofen was concentration-dependent (F2,32 
= 163; p < 0.001), but there was no significant difference in the response to baclofen 
between animals in the low corticosterone group and animals in the moderate 
corticosterone group. 
 
Discussion 
 
The present study aimed to clarify the characteristics of the GABA receptor-mediated  
regulation of 5-HT neuronal firing in the DRN and to examine the impact of moderate 
changes in corticosterone levels on the sensitivity of the neurons to  GABA receptor-
activation.  The firing of 5-HT neurons was inhibited by THIP and baclofen. 
Responses to THIP and baclofen were concentration dependent and were attenuated 
by the GABAA receptor antagonist bicuculline and the GABAB receptor antagonist 
phaclofen, respectively. Importantly, all individual neurons tested (in both naïve and 
corticosterone-treated animals) were found to respond to both GABAA and GABAB 
receptor agonists. Finally, we found that clamping corticosterone levels at low and 
moderate ranges failed to alter the response of presumed 5-HT neurons to either 
GABAA and GABAB receptor-mediated inhibition. 
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Characterization of GABA receptor-mediated regulation of 5-HT neuronal firing  
The selective GABAA receptor agonist THIP (Frolund et al., 1995) caused a clear 
concentration dependent inhibition of firing of 5-HT neurons. The inhibitory actions 
of THIP were completely blocked by bicuculline consistent with the action of THIP 
being GABAA receptor mediated (Bowery et al., 1984).  GABAA receptors on 5-HT 
neurons in the DRN reportedly contain the a3 subunit (Gao et al., 1993; Rodriguez-
Pallares et al., 2001). THIP is reported to have a lower affinity for GABAA receptors 
containing the a3 subunit than other α subunits and moreover is reported to be a 
partial agonist in oocytes expressing recombinant GABAA receptors containing the a3 
subunit (Ebert et al., 1997). However, in the present study THIP was found to be 
potent and efficacious in inhibiting 5-HT neuronal activity.   
 
Baclofen also caused inhibition of firing and again the effect was concentration 
dependent.  The effect of baclofen was attenuated by phaclofen indicative of its 
mediation by GABAB receptors (Kerr et al., 1987).  The effect of phaclofen, though 
marked, did not approach complete blockade of the action of baclofen. However, only 
one concentration was tested and it is possible that a higher concentration of 
phaclofen would have had a more complete effect.  Interestingly, neither bicuculline 
nor phaclofen alone increased firing. Although it has been previously shown that 
some 5-HT neurones display spontaneous GABAergic inhibitory postsynaptic 
currents in the slice preparation (Liu et al., 2000), under the recording conditions used 
in the present study we found no evidence of tonic GABAergic regulation of firing 
rate. 
 
It has previously been reported that the application of the GABAB agonist, baclofen 
(Innis and Aghajanian, 1987; Smith and Gallager, 1987) inhibits the firing of 5-HT 
neurons in the DRN, as does the application of the selective the GABAA agonist, 
muscimol (Sakai and Crochet, 2001).  Hence, the present data showing GABAA and 
GABAB receptor mediated inhibition of 5-HT neuronal firing are consistent with these 
previous data.  Importantly, in the present study we found that all DRN 5-HT neurons 
tested with both THIP and baclofen showed inhibitory responses to both agonists.  
This was the case both in naïve animals and in those from the different corticosterone 
treatment groups.  Thus, the bicuculline-insensitive inhibition of 5-HT neuronal firing 
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induced by GABA noted by Smith and Gallager (1987) may be explained by the fact 
that the activity of individual neurons is subject to modulation by both GABAA and 
GABAB receptor subtypes.  Futhermore, these functional data are consistent with 
immunocytochemical studies in which it has been found that the vast majority of 
5-HT neurons in DRN express the α3 subunit of the GABAA receptor (Gao et al., 
1993; Rodriguez-Pallares et al., 2001) and also that almost all 5-HT neurons express 
GABAB receptors (Wirtshafter and Sheppard, 2001; Varga et al., 2002).  
 
Although both GABAA and GABAB receptors inhibit 5-HT neuronal firing it is likely 
that they do so via different molecular mechanisms. Thus, GABAA receptor activation 
opens a chloride channel (Tallman and Gallager, 1985), whilst the GABAB receptor is 
reported to hyperpolarize neurons via activation of a G-protein linked inward 
rectifying potassium channel (GIRK; Innis and Aghajanian, 1987; Williams et al., 
1988). It is unclear whether the two receptor subtypes have different subcellular 
localizations or are differentially distributed in synaptic and extrasynaptic domains, 
but such factors may influence their functional roles (see below).   
 
In vivo studies have demonstrated that intra-raphe application of both GABAA and 
GABAB receptor agonists inhibits 5-HT release in the forebrain (Abellán et al., 2000; 
Tao and Auerbach, 2000). The present data would be consistent with these effects on 
release being a consequence of inhibition of 5-HT firing. Although, our data suggest a 
lack of GABAergic tone in the slice preparation, it is of interest that in vivo 
electrophysiological and microdialysis studies are indicative of significant GABAA 
receptor-mediated tone regulating 5-HT neuronal firing and release at least at some 
phases of the sleep-wake cycle (Levine and Jacobs, 1992; Gervasoni et al., 2000). In 
contrast, evidence suggests that GABAB receptor-activation does not normally 
contribute to the inhibitory regulation of 5-HT neuronal activity (Tao et al., 1996). 
Thus, whilst the GABAA receptor may be regarded as a tonic regulator, the GABAB 
receptor may be involved in phasic regulation.   
 
Effects of corticosterone on GABA receptor sensitivity  
The above data indicate that GABA receptors play a vital role in the regulation of 
5-HT neuronal activity.  Hence, changes in their sensitivity may have important 
consequences for 5-HT neuronal activity within the brain. This study also sought to 
 13 
determine if the sensitivity of  DRN 5-HT neurons to GABAA and GABAB receptor-
activation is altered by moderate changes in circulating corticosterone levels within 
the physiological range. THIP and baclofen responses were compared in two groups 
of animals with serum corticosterone clamped at different levels within the normal 
diurnal range. Animals in the low corticosterone group had serum corticosterone 
levels close to the trough of the normal diurnal rhythm, whilst the moderate 
corticosterone group had levels in the mid to high diurnal range (Judge et al., 2003, 
2004).  As there is evidence that the effects of corticosterone on the levels of mRNA 
of GABAA receptor subunits elsewhere in the brain is delayed (Kang et al., 1991; 
Stone et al., 2001), experiments were conducted after two weeks of corticosterone 
treatment.  
  
We found that moderate changes in circulating corticosterone levels within the 
physiological range had no significant effect on the sensitivity of DRN 5-HT neurons 
to GABAA receptor-activation. Thus across the whole concentration range tested, 
responses were similar in the low and moderate corticosterone groups. This is perhaps 
surprising since several studies have shown that the expression and pharmacological 
properties of GABAA receptors in other brain regions is sensitive to corticosterone 
(Majewska et al., 1985; Wilson and Biscardi, 1994; Orchinik et al., 1995, 2001). 
Although it is not immediately clear why in the present study we found no effect of 
alterations in corticosterone level, three possibilities present themselves: First, the 
differences in corticosterone levels in our two experimental groups may not have been 
sufficient to induce changes.  However, Orchinik et al. (1994) observed that variations 
in corticosterone of similar magnitude to those used here caused changes in 
hippocampal expression of mRNAs coding for GABAA subunits.  Moreover, we have 
previously shown that moderate changes in corticosterone levels alter the sensitivity 
of 5-HT neurones to a1-adrenoceptor-mediated excitation and 5-HT1A receptor-
mediated inhibition (Judge et al., 2003, 2004). Second, changes may be mediated 
through the mineralocorticoid rather than glucocorticoid receptor. Indeed, the ratio of 
mineralocorticoid to glucocorticoid receptors is far higher in hippocampus, where 
changes have been observed (Majewska et al., 1985; Wilson and Biscardi, 1994; 
Orchinik et al., 1995, 2001), than in the DRN (R. McQuade pers. comm.).   However, 
changes have also been observed in the cortex and hypothalamus (Majewska et al., 
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1985; Wilson and Biscardi, 1994; Orchinik et al., 1995) which, like the DRN, contain 
a low ratio of mineralocorticoid to glucocorticoid receptors (R. McQuade pers. 
comm.).  Third, those subunits which make up the GABAA receptor in the DRN may 
not be sensitive to corticosterone.  This last explanation seems the most plausible as 
the influence of corticosterone on the GABAA receptor has been reported to be 
subunit-specific (Orchinik et al., 1995).  To our knowledge the a3 subunit, which is 
expressed by DRN 5-HT neurons has not been shown to be corticosterone sensitive.   
 
We also found no effect of alterations in corticosterone on the response of 5-HT 
neurons to baclofen. The potential influence of corticosterone on the function of the 
GABAB receptor has been little studied.  In one study chronic corticosterone was 
shown to decrease the GABAB receptor modulation of cyclic AMP production in the 
cortex (Duman et al., 1986). However, in the DRN the GABAB receptor is coupled to 
a GIRK (Innis and Aghajanian, 1987; Williams et al., 1988) rather than to adenylate 
cyclase.  It has previously been shown that the expression of the mRNA encoding one 
of the GIRK subunits to which GABAB receptors in the DRN are coupled is 
influenced by corticosterone (Fairchild et al., 2003).  However, the present data would 
suggest that this is not mirrored in a functional change.  
 
Identity of neurons recorded 
In the light of a recent paper showing that some neurons in the DRN, which fire 
slowly and regularly, are not serotonergic (Allers and Sharp, 2003), it is important to 
comment on the identity and characteristics of the neurons recorded here.  It has 
previously been reported that GABAB receptors in the DRN are limited almost 
exclusively to 5-HT neurons (Wirtshafter and Sheppard, 2001).  Although we initially 
identified neurons on the basis of electrophysiological characteristics and inhibition 
by 5-HT, our finding that all neurons tested were inhibited by baclofen would indicate 
that it is highly unlikely that any of the neurons recorded here were non-serotonergic. 
It is possible that those slow firing, non-serotonergic, DRN neurons recorded in vivo 
(Allers and Sharp, 2003) are silent in vitro and therefore are not routinely recorded 
with the extracellular slice methodology employed here. 
 
Summary 
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In summary the present data demonstrate that the firing of 5-HT neurons in the DRN 
is regulated by GABAA and GABAB receptors and that individual neurons are 
influenced by both receptor subtypes. The sensitivity of 5-HT neurons to this GABA 
receptor-mediated regulation is not sensitive to moderate changes in corticosterone 
level. 
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Figure 1. Inhibitory responses of individual DRN 5-HT neurones to THIP (25 mM) 
and baclofen (Bac; 1 mM).  A) Recording from an individual neurone showing the 
decrease in basal firing rate following the application of THIP and baclofen for 
periods of 2 min as indicated by the bars.  Note that recordings have not been 
corrected for the perfusion lag (approximately 2 min). B) Recording from another 
individual neurone showing that the relative magnitude of the inhibitory responses to 
THIP and baclofen between neurones are variable. 
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Figure 2. Inhibitory responses of DRN 5-HT neurones to the GABAA receptor 
agonist THIP, in the absence and presence of the GABAA receptor antagonist, 
bicuculline (Bic). (A) Example of a recording showing the inhibitory responses to 
increasing concentrations of THIP of an individual 5-HT neurone in the absence and 
presence of bicuculline. Recording was made in the presence of 1 mM phenylephrine 
throughout.  THIP (5, 10 and 25 mM) was applied for periods of 2 min as indicated by 
the bars.  Note that recordings have not been corrected for the perfusion lag 
(approximately 2 min). THIP caused a concentration-dependent inhibition which 
reversed readily on wash-out of the drug.  Bicuculline (50 mM) applied for 3 min did 
not cause a change in basal firing but blocked the inhibitory response to THIP 
(25 mM). (B) Concentration-response relationships for inhibitory responses to THIP 
displayed by 5-HT neurones (n = 11). Data shown are mean ± SEM. (C) Inhibitory 
responses to THIP (25 mM) in the absence and presence of bicuculline (50 mM) 
displayed in individual 5-HT neurones. The responses from the same neurone are 
joined by a line.  
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Figure 3. Inhibitory responses of DRN 5-HT neurones to the GABAB receptor agonist 
baclofen, in the absence and presence of the GABAB receptor antagonist, phaclofen. 
(A) Example of a recording showing the inhibitory responses to increasing 
concentrations of baclofen of an individual 5-HT neurone in the absence and presence 
of phaclofen. The recording was made in the continuous presence of 1 
mM  phenylephrine and increasing concentrations of baclofen (1, 3 and 10 mM Bac) 
were applied for 2 min as indicated by the bars.  Note that the recording has not been 
corrected for the lag-time of the perfusion system (approximately 2 min).  Baclofen 
caused a concentration-dependent inhibition which readily reversed on wash-out.  
Application of phaclofen (200 mM Phac) for 3 min did not cause a change in basal 
firing but partially antagonized the inhibitory response to baclofen (3 mM). (B) 
Concentration-dependent inhibitory responses of 5-HT neurones to baclofen (n = 14). 
Data shown are mean ± SEM.  (C) The inhibitory responses of individual 5-HT 
neurones to baclofen (3 mM) in the absence and presence of phaclofen (200 mM). The 
responses from the same neurone are joined by a line.  
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Figure 4. Concentration-response relationships responses to GABA receptor agonists 
displayed by 5-HT neurones in slices from rats in the low corticosterone group (closed 
symbols; n = 9) and moderate corticosterone group (open symbols; n = 9).  (A) 
Inhibitory responses to increasing concentrations of THIP. (B) Inhibitory responses to 
baclofen. Data shown are mean ± SEM. 
 
 
